Hyderabad: In a shocking incident, a deceased man’s body was allegedly mauled by stray dogs inside the mortuary of the Government General Hospital in Jadcherla, Telangana, triggering outrage and prompting…
Back acne commonly known as bacne can be a "battlefield" of marks and deep scars because it's often out of sight and ignored. In this video, Dermatologist Dr Pravin Banodkar,…
USA: In the ACHIEVE-3 trial published in The Lancet, once-daily orforglipron demonstrated greater reductions in HbA1c and body weight compared with once-daily oral semaglutide in adults with type 2 diabetes.…
Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of substances including alcohol, cannabis,…
New Delhi: The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and weight-loss molecule, leading to…
China: A new study published in BMC Surgery suggests that intramedullary nailing may offer faster recovery and improved functional outcomes compared with dual-plate fixation in selected patients with proximal humeral…
A first-in-human, phase I single-arm trial has found that in-utero treatment of myelomeningocele, the most severe form of spina bifida, using allogeneic live stem cells was both feasible and safe.…
New Delhi: Emcure Pharmaceuticals has announced the signing of a distribution agreement with Roche for select products in the nephrology and transplant medicine portfolio, marking a significant step toward expanding…
New Delhi: The Appointments Committee of the Cabinet has cleared yet another extension for Dr Rajeev Singh Raghuvanshi as Drugs Controller (India) at the Central Drugs Standard Control Organisation (CDSCO),…
New Delhi: Cipla Limited has announced that it has entered into a 60:40 joint venture agreement with Kemwell Biopharma Private Limited for incorporation of a new joint venture company in…